Literature DB >> 23958905

The attenuated nine mile phase II clone 4/RSA439 strain of Coxiella burnetii is highly virulent for severe combined immunodeficient (SCID) mice.

Aminul Islam1, Michelle Lockhart, John Stenos, Stephen Graves.   

Abstract

The Nine Mile phase II clone 4 (NMIIC4) strain of Coxiella burnetii is an attenuated phase II strain that has lost the genes for virulence determinant type 1 lipopolysaccharide. These bacteria were very virulent for severe combined immunodeficient (SCID) mice. The lethal dose 50 (LD50) was ~10 bacteria. Infected SCID mice died between Day 28 and Day 53 post-infection. At termination of the experiment (Day 60) only 5 of 24 mice had survived. The degree of splenomegaly was directly related to the bacterial load in the SCID mice spleens. The NMIIC4 was avirulent in immunocompetent wild mice and bacterial DNA copies in splenic tissue were extremely low. The SCID mice that were inoculated with high doses of heat inactivated NMIIC4 C. burnetii were all alive at Day 60 and without splenomegaly. It appears that the phase I lipopolysaccharide present in virulent Nine Mile phase I but not in attenuated NMIIC4 is not the only virulence factor for C. burnetii.

Entities:  

Mesh:

Year:  2013        PMID: 23958905      PMCID: PMC3795117          DOI: 10.4269/ajtmh.12-0653

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  23 in total

1.  Studies on the immunological role of virenose and dihydrohydroxystreptose present in the Coxiella burnetii phase I lipopolysaccharide.

Authors:  Katarína Slabá; Ahmed Hussein; Peter Palkovic; Viktor Horváth; Rudolf Toman
Journal:  Ann N Y Acad Sci       Date:  2003-06       Impact factor: 5.691

2.  "Q" fever, a new fever entity: clinical features, diagnosis and laboratory investigation.

Authors:  E H Derrick
Journal:  Rev Infect Dis       Date:  1983 Jul-Aug

3.  Phase variation of Coxiella burnetii strain Priscilla: influence of this phenomenon on biochemical features of its lipopolysaccharide.

Authors:  P Ftácek; L Skultéty; R Toman
Journal:  J Endotoxin Res       Date:  2000

4.  Detecting and measuring small numbers of viable Coxiella burnetii.

Authors:  Michelle Lockhart; Aminul Islam; Stephen Graves; Stan Fenwick; John Stenos
Journal:  FEMS Immunol Med Microbiol       Date:  2011-12-05

5.  Identification and cloning potentially protective antigens of Coxiella burnetii using sera from mice experimentally infected with Nine Mile phase I.

Authors:  G Q Zhang; J E Samuel
Journal:  Ann N Y Acad Sci       Date:  2003-06       Impact factor: 5.691

6.  A severe combined immunodeficiency mutation in the mouse.

Authors:  G C Bosma; R P Custer; M J Bosma
Journal:  Nature       Date:  1983-02-10       Impact factor: 49.962

7.  A growth study of Coxiella burnetii Nine Mile Phase I and Phase II in fibroblasts.

Authors:  J D Miller; A T Curns; H A Thompson
Journal:  FEMS Immunol Med Microbiol       Date:  2004-11-01

8.  SCID mouse model for lethal Q fever.

Authors:  Masako Andoh; Takashi Naganawa; Akitoyo Hotta; Tsuyoshi Yamaguchi; Hideto Fukushi; Toshiaki Masegi; Katsuya Hirai
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

9.  Functional status of cells from lymphoid and myeloid tissues in mice with severe combined immunodeficiency disease.

Authors:  K Dorshkind; G M Keller; R A Phillips; R G Miller; G C Bosma; M O'Toole; M J Bosma
Journal:  J Immunol       Date:  1984-04       Impact factor: 5.422

10.  Lipopolysaccharide variation in Coxiella burnetti: intrastrain heterogeneity in structure and antigenicity.

Authors:  T Hackstadt; M G Peacock; P J Hitchcock; R L Cole
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

View more
  7 in total

Review 1.  Right on Q: genetics begin to unravel Coxiella burnetii host cell interactions.

Authors:  Charles L Larson; Eric Martinez; Paul A Beare; Brendan Jeffrey; Robert A Heinzen; Matteo Bonazzi
Journal:  Future Microbiol       Date:  2016-07-15       Impact factor: 3.165

2.  Host and Bacterial Factors Control Susceptibility of Drosophila melanogaster to Coxiella burnetii Infection.

Authors:  Reginaldo G Bastos; Zachary P Howard; Aoi Hiroyasu; Alan G Goodman
Journal:  Infect Immun       Date:  2017-06-20       Impact factor: 3.441

3.  Bayesian Validation of the Indirect Immunofluorescence Assay and Its Superiority to the Enzyme-Linked Immunosorbent Assay and the Complement Fixation Test for Detecting Antibodies against Coxiella burnetii in Goat Serum.

Authors:  Michael Muleme; John Stenos; Gemma Vincent; Angus Campbell; Stephen Graves; Simone Warner; Joanne M Devlin; Chelsea Nguyen; Mark A Stevenson; Colin R Wilks; Simon M Firestone
Journal:  Clin Vaccine Immunol       Date:  2016-06-06

4.  Coxiella burnetii-Infected NK Cells Release Infectious Bacteria by Degranulation.

Authors:  Svea Matthiesen; Luca Zaeck; Kati Franzke; Rico Jahnke; Charlie Fricke; Michael Mauermeir; Stefan Finke; Anja Lührmann; Michael R Knittler
Journal:  Infect Immun       Date:  2020-10-19       Impact factor: 3.441

5.  The SCID Mouse Model for Identifying Virulence Determinants in Coxiella burnetii.

Authors:  Erin J van Schaik; Elizabeth D Case; Eric Martinez; Matteo Bonazzi; James E Samuel
Journal:  Front Cell Infect Microbiol       Date:  2017-02-03       Impact factor: 5.293

6.  Characterization of Coxiella burnetii strains from ruminants in a Galleria mellonella host-based model.

Authors:  A Selim; E Yang; E Rousset; R Thiéry; K Sidi-Boumedine
Journal:  New Microbes New Infect       Date:  2018-03-02

7.  MyD88 Is Required for Efficient Control of Coxiella burnetii Infection and Dissemination.

Authors:  Lisa Kohl; Inaya Hayek; Christoph Daniel; Jan Schulze-Lührmann; Barbara Bodendorfer; Anja Lührmann; Roland Lang
Journal:  Front Immunol       Date:  2019-02-08       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.